GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Laboratory Corp of America Holdings (FRA:LAB) » Definitions » Shiller PE Ratio

Laboratory of America Holdings (FRA:LAB) Shiller PE Ratio : 16.39 (As of Apr. 30, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Laboratory of America Holdings Shiller PE Ratio?

As of today (2024-04-30), Laboratory of America Holdings's current share price is €185.00. Laboratory of America Holdings's E10 for the quarter that ended in Mar. 2024 was €11.29. Laboratory of America Holdings's Shiller PE Ratio for today is 16.39.

The historical rank and industry rank for Laboratory of America Holdings's Shiller PE Ratio or its related term are showing as below:

FRA:LAB' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.47   Med: 19.94   Max: 26.91
Current: 16.47

During the past years, Laboratory of America Holdings's highest Shiller PE Ratio was 26.91. The lowest was 12.47. And the median was 19.94.

FRA:LAB's Shiller PE Ratio is ranked better than
71.79% of 78 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.045 vs FRA:LAB: 16.47

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Laboratory of America Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was €2.475. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €11.29 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Laboratory of America Holdings Shiller PE Ratio Historical Data

The historical data trend for Laboratory of America Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratory of America Holdings Shiller PE Ratio Chart

Laboratory of America Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.66 20.71 24.74 16.52 18.49

Laboratory of America Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.78 16.42 15.80 18.49 17.63

Competitive Comparison of Laboratory of America Holdings's Shiller PE Ratio

For the Diagnostics & Research subindustry, Laboratory of America Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratory of America Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Laboratory of America Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Laboratory of America Holdings's Shiller PE Ratio falls into.



Laboratory of America Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Laboratory of America Holdings's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=185.00/11.29
=16.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratory of America Holdings's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Laboratory of America Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.475/129.4194*129.4194
=2.475

Current CPI (Mar. 2024) = 129.4194.

Laboratory of America Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 1.207 100.560 1.553
201409 1.234 100.428 1.590
201412 1.127 99.070 1.472
201503 0.037 99.621 0.048
201506 1.479 100.684 1.901
201509 1.336 100.392 1.722
201512 1.019 99.792 1.322
201603 1.419 100.470 1.828
201606 1.744 101.688 2.220
201609 1.524 101.861 1.936
201612 1.659 101.863 2.108
201703 1.636 102.862 2.058
201706 1.584 103.349 1.984
201709 1.384 104.136 1.720
201712 5.754 104.011 7.160
201803 1.354 105.290 1.664
201806 1.943 106.317 2.365
201809 2.657 106.507 3.229
201812 1.371 105.998 1.674
201903 1.646 107.251 1.986
201906 1.708 108.070 2.045
201909 2.043 108.329 2.441
201912 2.088 108.420 2.492
202003 -2.959 108.902 -3.516
202006 2.105 108.767 2.505
202009 6.087 109.815 7.174
202012 7.842 109.897 9.235
202103 6.569 111.754 7.607
202106 3.951 114.631 4.461
202109 5.143 115.734 5.751
202112 5.089 117.630 5.599
202203 4.749 121.301 5.067
202206 3.661 125.017 3.790
202209 3.939 125.227 4.071
202212 0.812 125.222 0.839
202303 2.232 127.348 2.268
202306 1.957 128.729 1.968
202309 1.977 129.860 1.970
202312 -1.806 129.419 -1.806
202403 2.475 129.419 2.475

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Laboratory of America Holdings  (FRA:LAB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Laboratory of America Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Laboratory of America Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratory of America Holdings (FRA:LAB) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.